Activin and Inhibin

GSK2850163 is a novel inhibitor of inositol-requiring enzyme-1 alpha ( IRE1α ) which can inhibit IRE1α kinase activity and RNase activity with IC 50 s of 20 and 200 nM, respectively.In VitroGSK2850163 is a novel inhibitor of inositol-requiring

GSK2850163 is a novel inhibitor of inositol-requiring enzyme-1 alpha ( IRE1α ) which can inhibit IRE1α kinase activity and RNase activity with IC 50 s of 20 and 200 nM, respectively.In VitroGSK2850163 is a novel inhibitor of inositol-requiring

GSK2879552 an orally active, selective and irreversible inhibitor of lysine specific demethylase 1 (LSD1/ KDM1A) , with potential antineoplastic activityIn VitroGSK2879552 inhibits KDM1A histone demethylase activity, inducing differentiation of

GSK2879552 an orally active, selective and irreversible inhibitor of lysine specific demethylase 1 (LSD1/ KDM1A) , with potential antineoplastic activityIn VitroGSK2879552 inhibits KDM1A histone demethylase activity, inducing differentiation of

GSK2879552 an orally active, selective and irreversible inhibitor of lysine specific demethylase 1 (LSD1/ KDM1A) , with potential antineoplastic activityIn VitroGSK2879552 inhibits KDM1A histone demethylase activity, inducing differentiation of

GSK2879552 an orally active, selective and irreversible inhibitor of lysine specific demethylase 1 (LSD1/ KDM1A) , with potential antineoplastic activityIn VitroGSK2879552 inhibits KDM1A histone demethylase activity, inducing differentiation of

GSK2879552 an orally active, selective and irreversible inhibitor of lysine specific demethylase 1 (LSD1/ KDM1A) , with potential antineoplastic activityIn VitroGSK2879552 inhibits KDM1A histone demethylase activity, inducing differentiation of

GSK2879552 an orally active, selective and irreversible inhibitor of lysine specific demethylase 1 (LSD1/ KDM1A) , with potential antineoplastic activityIn VitroGSK2879552 inhibits KDM1A histone demethylase activity, inducing differentiation of

GSK2983559 is an orally active and potent receptor interacting protein 2 ( RIP2 ) kinase inhibitor. GSK2983559 blocks many proinflammatory cytokine responses in vivo and in human inflammatory bowel disease explant samples.Appearance:SolidIC50&amp:

GSK2983559 is an orally active and potent receptor interacting protein 2 ( RIP2 ) kinase inhibitor. GSK2983559 blocks many proinflammatory cytokine responses in vivo and in human inflammatory bowel disease explant samples.Appearance:SolidIC50&amp:

GSK2983559 is an orally active and potent receptor interacting protein 2 ( RIP2 ) kinase inhibitor. GSK2983559 blocks many proinflammatory cytokine responses in vivo and in human inflammatory bowel disease explant samples.Appearance:SolidIC50&amp:

GSK2983559 is an orally active and potent receptor interacting protein 2 ( RIP2 ) kinase inhibitor. GSK2983559 blocks many proinflammatory cytokine responses in vivo and in human inflammatory bowel disease explant samples.Appearance:SolidIC50&amp: